AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CABA
  4. [SCHEDULE 13G/A] Cabaletta Bio, Inc. SEC Filing

[SCHEDULE 13G/A] Cabaletta Bio, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock CABA logo
Cabaletta Bio, Inc.

NASDAQ:CABA

CABA Rankings

#4522 Ranked by Market Cap
N/A Ranked by Dividends

CABA Latest News

Aug 7, 2025
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
Jun 11, 2025
Cabaletta Bio Announces Pricing of Public Offering of Securities
Jun 11, 2025
Cabaletta Bio Announces Proposed Public Offering of Securities
Jun 11, 2025
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
May 29, 2025
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

CABA Latest SEC Filings

Aug 12, 2025
[SCHEDULE 13G/A] Cabaletta Bio, Inc. SEC Filing
Aug 11, 2025
[SCHEDULE 13G/A] Cabaletta Bio, Inc. SEC Filing
Aug 7, 2025
[S-3] Cabaletta Bio, Inc. Shelf Registration Statement
Aug 7, 2025
[10-Q] Cabaletta Bio, Inc. Quarterly Earnings Report
Aug 7, 2025
[8-K] Cabaletta Bio, Inc. Reports Material Event

CABA Stock Data

121.65M
89.95M
1.68%
50.28%
7.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
PHILADELPHIA